Update
$Werewolf Therapeutics(HOWL.US$ Werewolf Therapeutics Presents Preliminary Monotherapy Data From Phase 1/1b Clinical Trial Establishing Proof of Mechanism for WTX-124 At the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
